The Impact of Migraine in society
A recent study published in the Value in Health journal set out to get a grip on the burden of migraine in the United States. A survey was done of various articles written in the past, and the results really go way beyond the USA and beyond economics and insurance.
I thought it would be worth sharing this little quote. It won’t be anything new to many of you, but it does emphasize the importance of fighting migraine.
Migraine affects millions of individuals worldwide, generally during the most productive years of a person’s life. Studies show that migraineurs are underdiagnosed, undertreated, and experience substantial decreases in functioning and productivity, which in turn translates into diminished quality of life for individuals, and financial burdens to both health-care systems and employers. Economic evaluations of migraine therapies have evolved with new clinical developments beginning with cognitive-behavioral therapy, introduction of triptans, concern over medication overuse, and emergence of migraine prophylaxis. Now recent clinical studies suggest that migraine may be a progressive disease with cardiovascular, cerebrovascular, and long-term neurologic effects.
Read the full story at The Burden of Migraine in the United States: Current and Emerging Perspectives on Disease Management and Economic Analysis.